Eating Disorders Trial, Recruiting NCT06814002 Sponsor: Umeå University Condition: Eating Disorders
Back to Eating Disorders

Eating Disorders Trial, Recruiting

NCT06814002
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Female individuals between 13 and 18 years of age
  • People who are currently patients at the eating disorder clinic
  • People who have been newly diagnosed with anorexia nervosa (AN) according to standard diagnostic guidelines (DSM-5)
  • People who have not yet received any treatment for anorexia nervosa
  • Healthy volunteers without an eating disorder may also be included, matched to participants by age, sex, and education level

Who may not be able to join:

  • People with one or more ongoing medical conditions that could interfere with the study or affect its results
  • People taking medications that affect hormone levels or eating behaviours
  • People with a serious psychiatric condition other than anorexia nervosa, such as schizophrenia, major depressive disorder, or bipolar disorder
  • People who are currently using drugs, are pregnant, or may be pregnant
  • People considered at high risk of a serious complication called refeeding syndrome, or other severe complications related to eating disorders
  • People who would be unable to follow the study's nutritional program
  • People with allergies to foods included in the meals provided during the study
  • People with cognitive difficulties that would prevent understanding of the study or the consent process
  • People for whom MRI scanning is not safe — for example, those with a pacemaker, certain implants, or severe claustrophobia
  • People whose fasting blood sugar level is above 6.0 mmol/l on the morning of the study, which may indicate non-compliance with overnight fasting or a blood sugar condition
  • For healthy volunteers only: people who have a current or past eating disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olof Lagerlöf, MD, PhD, Umea University

Phone: +46 90-785 00 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Umeå University
Registry
ClinicalTrials.gov
Start date
15 February 2025
Est. completion
31 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Magnetic Resonance Imaging

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov